Blogs
Scientific insights
The development of new drugs is often limited or even halted by their side effects on platelet function. In drug discovery, identifying compounds that might
Read more
In our blog series on anti-platelet therapy, we have covered the development of both intravenous and oral therapies and the role of platelet function testing
Read more
In the latest instalment of our antiplatelet therapy series, we take a look at platelet function testing and how requirements for it have shifted throughout
Read more
In the second instalment of our antiplatelet therapy series, we take a look at intravenous (IV) antiplatelet therapy and how it came to be used.
Read more
While it is not a regulatory requirement to test the effect of all drugs on platelets, platelet testing can be an important stage of the
Read more
It is now 50 years since the first randomised, controlled trial of aspirin in the secondary prevention of mortality from myocardial infarction (MI)[1]. Although the
Read more
Perspectives and updates
We are thrilled to welcome Payash Bahuguna to the Platelet Services team as Director of Business Development. As Director of Business Development, Payash will bring
Read more
The Platelet Services team were pleased to sponsor and participate in this year’s meeting of the Platelet Society held in the Dalton Building at Manchester
Read more
The Platelet Services team returned home buoyant from a successful trip to Orlando for the Society of Toxicology 64th Annual Meeting and ToxExpo. It was
Read more
From working on exciting client projects to attending industry events across the globe, it’s been another super busy but rewarding year here at Platelet Services
Read more
At the beginning of September the Platelet Services team were delighted to attend Eurotox 2024, held at the Tivoli Hotel and Congress Centre in Copenhagen.
Read more
In the latest instalment of our ‘Meet the Team’ series, we sat down with Bob Humphries, Platelet Services’ Non-Executive Director and Drug Discovery Advisor, to
Read more
